Who
Bruce Culleton
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, ProKidney.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Aug 2023
- Last trade
- 1 Mar 2026
- Last filed
- 3 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Mar 2026filed 3 Mar 2026 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000,000 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000,000 at $0.00 | filing |
| 1 Mar 2025filed 4 Mar 2025 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,796,000 at $0.00 | filing |
| 13 Sep 2024filed 16 Sep 2024 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 3 Dec 2023filed 5 Dec 2023 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,000,000 at $0.00 | filing |
| 1 Aug 2023filed 3 Aug 2023 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —485,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.